Skip to main content

Table 2 Resistin levels and inflammatory and endothelial markers in T2DM and control women participating to the study

From: Resistin levels and inflammatory and endothelial dysfunction markers in obese postmenopausal women with type 2 diabetes mellitus

 

Control women

All T2DM women

T2DM women without CHD

T2DM women with CHD

P1

P2

Age- adjusted P2

n

55

132

96

36

   

Resistin(ng/ml)

10.31 ± 4.28

10.27 ± 4.11

9.50 ± 3.33

12.43 ± 5.21

0.953

< 0.001

0.013

hsPCR (mg/L)

2.97 ± 3.27

5.54 ± 6.42

5.83 ± 7.34

4.90 ± 4.55

0.0132

0.452

0.682

IL-6 (pg/ml)

2.17 ± 2.07

2.87 ± 2.07

2.72 ± 3.84

3.35 ± 2.03

0.109

0.317

0.913

sVCAM1 (ng/ml)

715.07 ± 202.63

768.65 ± 313.48

707.32 ± 194.80

940.11 ± 481.97

0.245

< 0.001

0.118

tHcy (μmol/L)

11.47 ± 4.58

12.77 ± 5.94

11.68 ± 5.01

15.92 ± 7.25

0.165

< 0.001

0.799

  1. Data are n, means ± DS
  2. P1: P value for the comparison between T2DM and control women participating to the study
  3. P 2: P value for the comparison between T2DM women with and without CHD